Moreover, a cluster of deleterious de novo mutations in TRIO GEF1 and the spectrin repeat domain were recently identified in neurodevelopmental disorders including ASDs and/or ID [16–18], suggesting that Trio dysfunction is a risk factor for neurodevelopmental diseases. Here, ARHGEF1 is linked to neurodevelopmental disorder.